Clinical Trials Logo

Qi Zhi Tong Luo Capsule clinical trials

View clinical trials related to Qi Zhi Tong Luo Capsule.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04301466 Completed - Clinical trials for Randomized Controlled Trial

Efficacy and Safety of Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment

Start date: July 16, 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Qi Zhi Tong Luo (QZTL) capsule, a traditional Chinese herbal medicine, which was used to treat stoke-related symptoms, include trouble speaking, paralysis and trouble walking. This study aimed to evaluate the efficacy and safety of QZTL capsule in the treatment of vascular cognitive impairment. This study was designed as randomized, double-blind, parallel, placebo-controlled, multicentre trial. It consisted of a single-blind run-in period using placebo only (2 weeks) and a double-blind treatment phase after randomization (24 weeks), and follow-up 12 weeks after withdrawal.The primary efficacy variables included changes from baseline in the Clinical Dementia Rating scale-Sum Box (CDR-SB) and the Mini-mental State Examination (MMSE) after 24 weeks of treatment. The secondary efficacy measurements include the Clock Drawing Test (CDT), Hopkins Verbal Learning Test (HVLT) and Ability of Daily Living (ADL).